Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Hu

Showing results (1271-1280 of 1,603) with videos related to

Pageof 161
Sort By:
Chinese Medical Journal|February 1, 1989
Double-blind crossover controlled study on antiepilepsirineL Wang, D Y Zhao, Z H Zhang, et al.
Die Pharmazie|December 6, 2012
SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2/M phase arrestJ Y Li, J Y Huang, B Xing, et al.
Cell Death & Disease|July 30, 2016
Tumorigenic potential is restored during differentiation in fusion-reprogrammed cancer cellsJ Yao, L Zhang, L Hu, et al.
Rheumatology (Oxford, England)|December 1, 2006
The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch populationJ Wesoly, X Hu, M M Thabet, et al.
JAMA Surgery|September 8, 2021
Patient-Centered Decision-making for Postoperative Narcotic-Free Endocrine Surgery: A Randomized Clinical TrialCatherine Y Zhu, Max A Schumm, Theodore X Hu, et al.
Cancer Research|February 1, 1994
Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locusM K Dodson, W A Cliby, H J Xu, et al.
Diabetologia|May 19, 2009
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population of mainland ChinaY Liu, D Z Zhou, D Zhang, et al.
Physical Review. E|November 18, 2022
First-principles equation of state of CHON resin for inertial confinement fusion applicationsShuai Zhang, Valentin V Karasiev, Nathaniel Shaffer, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 4, 2024
[Etiological characteristics of <i>Brucella melitensis</i> in Henan Province, 2013-2022]J Y Zhao, W R Song, B F Zhang, et al.
Neoplasma|July 14, 2020
Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (docetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancerW P Li, T Zhu, M X Hu, et al.
Pageof 161

Showing results (1271-1280 of 1,603) with videos related to

Sort By:
Pageof 161
Chinese Medical Journal|February 1, 1989
Double-blind crossover controlled study on antiepilepsirineL Wang, D Y Zhao, Z H Zhang, et al.
Die Pharmazie|December 6, 2012
SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2/M phase arrestJ Y Li, J Y Huang, B Xing, et al.
Cell Death & Disease|July 30, 2016
Tumorigenic potential is restored during differentiation in fusion-reprogrammed cancer cellsJ Yao, L Zhang, L Hu, et al.
Rheumatology (Oxford, England)|December 1, 2006
The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch populationJ Wesoly, X Hu, M M Thabet, et al.
JAMA Surgery|September 8, 2021
Patient-Centered Decision-making for Postoperative Narcotic-Free Endocrine Surgery: A Randomized Clinical TrialCatherine Y Zhu, Max A Schumm, Theodore X Hu, et al.
Cancer Research|February 1, 1994
Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locusM K Dodson, W A Cliby, H J Xu, et al.
Diabetologia|May 19, 2009
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population of mainland ChinaY Liu, D Z Zhou, D Zhang, et al.
Physical Review. E|November 18, 2022
First-principles equation of state of CHON resin for inertial confinement fusion applicationsShuai Zhang, Valentin V Karasiev, Nathaniel Shaffer, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 4, 2024
[Etiological characteristics of <i>Brucella melitensis</i> in Henan Province, 2013-2022]J Y Zhao, W R Song, B F Zhang, et al.
Neoplasma|July 14, 2020
Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (docetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancerW P Li, T Zhu, M X Hu, et al.
Pageof 161